Primary Duodenal Melanoma: Challenges in Diagnosis and Management of a Rare Entity.

Q3 Medicine
Konstantina Dimopoulou, Anastasia Dimopoulou, Dimitra Dimopoulou, Eleni Panopoulou, Andriani Zacharatou, Paul Patapis, Nikolaos Zavras
{"title":"Primary Duodenal Melanoma: Challenges in Diagnosis and Management of a Rare Entity.","authors":"Konstantina Dimopoulou,&nbsp;Anastasia Dimopoulou,&nbsp;Dimitra Dimopoulou,&nbsp;Eleni Panopoulou,&nbsp;Andriani Zacharatou,&nbsp;Paul Patapis,&nbsp;Nikolaos Zavras","doi":"10.14712/18059694.2023.2","DOIUrl":null,"url":null,"abstract":"<p><p>Primary melanoma of the duodenum is an extremely rare, aggressive and life-threatening malignant neoplasm. Published data regarding the effectiveness of current treatment strategies is limited, and our knowledge relies mostly on sporadic case reports. The diagnosis of primary duodenal melanoma is challenging and is based on the patient's medical history and findings from physical examination and radiological and endoscopic imaging as well as proper and careful pathological examinations of the tumor. Despite the many advances in cancer treatment, the prognosis for patients with this type of melanoma remains extremely poor. Delayed diagnosis at advanced disease stage, the general aggressive behavior of this neoplasm, the technical difficulty in achieving complete surgical resection, along with the rich vascular and lymphatic drainage of the intestinal mucosa, all have a negative impact on patients' outcome. In the present review, we aimed to collect and summarize the currently available data in the literature regarding the pathogenesis, clinical features, diagnosis, management and long-term outcomes of this rare, malignant tumor, in order to expand knowledge of its biological behavior and investigate optimal therapeutic options for these patients. Additionally, we present our experience of a case involving a 73-year-old female with primary duodenal melanoma, who was successfully treated with complete surgical resection.</p>","PeriodicalId":35758,"journal":{"name":"Acta medica (Hradec Kralove)","volume":"65 4","pages":"125-132"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta medica (Hradec Kralove)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14712/18059694.2023.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Primary melanoma of the duodenum is an extremely rare, aggressive and life-threatening malignant neoplasm. Published data regarding the effectiveness of current treatment strategies is limited, and our knowledge relies mostly on sporadic case reports. The diagnosis of primary duodenal melanoma is challenging and is based on the patient's medical history and findings from physical examination and radiological and endoscopic imaging as well as proper and careful pathological examinations of the tumor. Despite the many advances in cancer treatment, the prognosis for patients with this type of melanoma remains extremely poor. Delayed diagnosis at advanced disease stage, the general aggressive behavior of this neoplasm, the technical difficulty in achieving complete surgical resection, along with the rich vascular and lymphatic drainage of the intestinal mucosa, all have a negative impact on patients' outcome. In the present review, we aimed to collect and summarize the currently available data in the literature regarding the pathogenesis, clinical features, diagnosis, management and long-term outcomes of this rare, malignant tumor, in order to expand knowledge of its biological behavior and investigate optimal therapeutic options for these patients. Additionally, we present our experience of a case involving a 73-year-old female with primary duodenal melanoma, who was successfully treated with complete surgical resection.

原发性十二指肠黑色素瘤:罕见疾病诊断与治疗的挑战。
原发性十二指肠黑色素瘤是一种极为罕见、侵袭性强且危及生命的恶性肿瘤。关于当前治疗策略有效性的公开数据有限,我们的知识主要依赖于零星的病例报告。原发性十二指肠黑色素瘤的诊断是具有挑战性的,它基于患者的病史和体格检查、放射学和内窥镜成像的结果,以及对肿瘤进行适当和仔细的病理检查。尽管癌症治疗取得了许多进步,但这种类型的黑色素瘤患者的预后仍然非常差。晚期诊断延迟、肿瘤具有普遍的侵袭性、手术完全切除的技术难度,以及肠黏膜丰富的血管和淋巴引流,都对患者的预后产生了不利影响。在本综述中,我们旨在收集和总结目前文献中关于这种罕见恶性肿瘤的发病机制、临床特征、诊断、治疗和长期预后的资料,以扩大对其生物学行为的认识,并探讨这些患者的最佳治疗方案。此外,我们提出我们的经验,涉及一个73岁的女性原发性十二指肠黑色素瘤,谁是成功地治疗了完全手术切除。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta medica (Hradec Kralove)
Acta medica (Hradec Kralove) Medicine-Medicine (all)
CiteScore
1.10
自引率
0.00%
发文量
8
审稿时长
20 weeks
期刊介绍: Acta Medica (Hradec Králové) is a multidisciplinary medical journal published by the Faculty of Medicine in Hradec Králové - Karolinum Press, the publishing house of Charles University. The journal is peer-reviewed and published quarterly in both paper and electronic form. The language of Acta Medica is English. Offerings include review articles, original articles, brief communications, case reports, announcements and notices. The journal was founded in 1958 under the title "A Collection of Scientific Works of the Charles University Faculty of Medicine in Hradec Kralove."
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信